2 terminated, 1 completed, 1 unknown. 3 Phase 2, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Terminated 1, Unknown 1 |
| Not applicable | 1 | Terminated 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Calcium Aluminosilicate: new trials by email Literature Review of Calcium Aluminosilicate trials Research Report on Calcium Aluminosilicate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CASAD for Severe Diarrhea in the Emergency Department Calcium Alumina-Silicate (CASAD), Placebo, Questionnaire - Cancer, Diarrhea | Not applicable | Terminated | M.D. Anderson Cancer Center | 2 | 2013-12-01 | 2018-07-26 |
| The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer CASAD - Diarrhea, Medullary Thyroid Cancer | Phase 1 / Phase 2 | Unknown | Salient Pharmaceuticals Incorporated | 10 | 2012-11-01 | 2012-12-03 |
| Proof-of-Concept, Calcium Aluminosilicate Anti-Diarrheal (CASAD) for Treatment of Clostridium Difficile Infection Calcium Aluminosilicate Anti-Diarrheal (CASAD) - Diarrhoea, Clostridium Difficile | Phase 2 | Terminated | Salient Pharmaceuticals Incorporated | 2 | 2012-03-01 | 2013-03-08 |
| Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving Irinotecan calcium aluminosilicate anti-diarrheal, placebo - Chemotherapeutic Agent Toxicity, Colorectal Cancer | Phase 2 | Completed | M.D. Anderson Cancer Center | 100 | 2009-02-04 | 2020-12-02 |
Diarrhea (4) · Carcinoma, Medullary (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Infections (1) · Neoplasms (1) · Rectal Neoplasms (1) · Spasm (1)
M.D. Anderson Cancer Center (2) · Salient Pharmaceuticals Incorporated (2)
United States (4)
Aarthi Narasimhan, MD (1) · Brian K. Kee, MD (1) · Michael J. Fisch, MD, MPH, FACP (1) · Sai-Ching J. Yeung, MD,PHD (1)